Kojima Takuro, Imamura Tomohiko, Osada Yousuke, Muraji Shouta, Nakano Marie, Oyanagi Takayuki, Yoshiba Shigeki, Kobayashi Toshiki, Sumitomo Naokata
Division of Pediatric Cardiology,Saitama Medical University International MedicalCenter, Saitama,Japan.
Cardiol Young. 2018 Dec;28(12):1426-1430. doi: 10.1017/S1047951118001452. Epub 2018 Sep 3.
Catheter interventions for residual lesions in the early postoperative period after CHD operations are still not established as a reliable treatment option.
We retrospectively reviewed our institutional experience of cardiac catheterisations and catheter interventions performed in the early postoperative period. We classified our patients into two groups. The "hyper" acute phase group - operation to cardiac catheterisation of ⩽7 days - and acute phase group - operation to cardiac catheterisation from 7 to 30 days.
Of the 47 patients, catheter interventions were performed in 38 patients (81%). The success rate of the intervention was 96% in the acute phase group and 90% in the "hyper" acute phase group. The overall success rate was 95%. There were two self-limited complications in the acute phase group, but not in the "hyper" acute phase group. There were four cases of catheter interventions performed for a newly reconstructed aortic arch, and those procedures were also safe and effective.
Cardiac catheterisations and catheter interventions were safe and effective not only in the early postoperative period but also in the very early postoperative period. Catheter interventions for the left-sided heart in the early postoperative period were also safe and effective.
先天性心脏病(CHD)手术后早期对残余病变进行导管介入治疗尚未成为一种可靠的治疗选择。
我们回顾性分析了我院在术后早期进行心脏导管检查和导管介入治疗的经验。我们将患者分为两组。“超”急性期组——手术至心脏导管检查时间≤7天——和急性期组——手术至心脏导管检查时间为7至30天。
47例患者中,38例(81%)接受了导管介入治疗。急性期组介入治疗成功率为96%,“超”急性期组为90%。总体成功率为95%。急性期组有2例自限性并发症,“超”急性期组无。有4例针对新重建主动脉弓进行的导管介入治疗,这些操作也安全有效。
心脏导管检查和导管介入治疗不仅在术后早期而且在术后极早期都是安全有效的。术后早期对左侧心脏进行导管介入治疗也是安全有效的。